Arkema SA (OTCMKTS:ARKAY – Get Free Report) was the recipient of a significant decline in short interest in February. As of February 27th, there was short interest totaling 58 shares, a decline of 96.7% from the February 12th total of 1,744 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 6,662 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 6,662 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short.
Analyst Ratings Changes
Several research firms have recently issued reports on ARKAY. The Goldman Sachs Group raised shares of Arkema from a “hold” rating to a “buy” rating in a research report on Tuesday, February 10th. Barclays lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 11th. Zacks Research cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 6th. Kepler Capital Markets lowered Arkema from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 27th. Finally, Deutsche Bank Aktiengesellschaft lowered Arkema from a “buy” rating to a “hold” rating in a research report on Monday, November 24th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Reduce”.
Get Our Latest Stock Analysis on Arkema
Arkema Stock Up 2.2%
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Read More
- Five stocks we like better than Arkema
- “I just bought 10,000 shares of a $5 stock…”
- Have $500? Invest in Elon’s AI Masterplan
- What a Former CIA Agent Knows About the Coming Collapse
- The gold chart Wall Street is terrified of…
- What central banks are doing with gold right now
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
